| Oct 25 |
Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week
|
| Oct 23 |
Disc Medicine draws but at Jefferies on lead asset
|
| Oct 23 |
Disc Medicine appoints Rahul Kaushik as chief technology officer
|
| Oct 23 |
Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer
|
| Oct 11 |
Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week
|
| Oct 6 |
Disc Medicine: Achieving Functional Endpoint More Important
|
| Sep 19 |
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer
|
| Aug 30 |
Disc Medicine to Participate in Upcoming Investor Conferences
|
| Aug 10 |
Here's Why We're Not Too Worried About Disc Medicine's (NASDAQ:IRON) Cash Burn Situation
|
| Aug 9 |
Disc Medicine GAAP EPS of -$1.03
|
